My research focuses on the rational design, synthesis, and evaluation of novel small molecules targeting complex neuropsychiatric and neurodegenerative disorders. A primary pillar of my work is optimising treatments for central nervous system disorders.

My research involves chemical synthesis, radioligand binding studies, animal behavioural studies and adenosine antagonist drug design for central nervous system diseases such as Parkinson’s Disease and Alzheimer’s disease.

Douglas William Oliver, (South African citizen) was born on 29th March 1954 (one of an identical twin) in Johannesburg, South Africa. He enrolled as a pharmacy student at the North-West University (former Potchefstroom University for CHE) in 1973 after his matric (Randburgse Hoërskool, 1971) and military training in Oudsthoorn (1972). He is pharmacist registered with the South Africa Pharmacy Council and has served in more than 50 pharmacies in South Africa and Namibia.